485 related articles for article (PubMed ID: 22373961)
1. APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).
Lalonde R; Fukuchi K; Strazielle C
Neurosci Biobehav Rev; 2012 May; 36(5):1357-75. PubMed ID: 22373961
[TBL] [Abstract][Full Text] [Related]
2. Neurologic and motor dysfunctions in APP transgenic mice.
Lalonde R; Fukuchi K; Strazielle C
Rev Neurosci; 2012; 23(4):363-79. PubMed ID: 23089603
[TBL] [Abstract][Full Text] [Related]
3. Effects of tooth loss on behavioral and psychological symptoms of dementia in app knock-in mice.
Furukawa M; Tada H; Raju R; Wang J; Yokoi H; Yamada M; Shikama Y; Saito T; Saido TC; Matsushita K
J Oral Biosci; 2024 Jun; 66(2):329-338. PubMed ID: 38521152
[TBL] [Abstract][Full Text] [Related]
4. Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Abeta-bearing fragment is associated with reduced NMDA receptor density.
Boon WC; van den Buuse M; Wegener N; Martin S; Chua HK; Bush AI; Masters CL; Adlard PA; Li QX
Behav Brain Res; 2010 May; 209(1):27-35. PubMed ID: 20085783
[TBL] [Abstract][Full Text] [Related]
5. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
[TBL] [Abstract][Full Text] [Related]
6. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
[TBL] [Abstract][Full Text] [Related]
7. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
[TBL] [Abstract][Full Text] [Related]
8. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances.
Vloeberghs E; Van Dam D; Engelborghs S; Nagels G; Staufenbiel M; De Deyn PP
Eur J Neurosci; 2004 Nov; 20(10):2757-66. PubMed ID: 15548219
[TBL] [Abstract][Full Text] [Related]
9. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease.
Vijayan M; Bose C; Reddy PH
Mitochondrion; 2021 Jul; 59():17-29. PubMed ID: 33839321
[TBL] [Abstract][Full Text] [Related]
11. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes.
Arendash GW; King DL; Gordon MN; Morgan D; Hatcher JM; Hope CE; Diamond DM
Brain Res; 2001 Feb; 891(1-2):42-53. PubMed ID: 11164808
[TBL] [Abstract][Full Text] [Related]
12. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
13. Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia.
Van der Jeugd A; Blum D; Raison S; Eddarkaoui S; Buée L; D'Hooge R
Behav Brain Res; 2013 Apr; 242():34-9. PubMed ID: 23247080
[TBL] [Abstract][Full Text] [Related]
14. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
[TBL] [Abstract][Full Text] [Related]
15. Reduction in open field activity in the absence of memory deficits in the App
Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ
Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197
[TBL] [Abstract][Full Text] [Related]
16. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
Umeda T; Kimura T; Yoshida K; Takao K; Fujita Y; Matsuyama S; Sakai A; Yamashita M; Yamashita Y; Ohnishi K; Suzuki M; Takuma H; Miyakawa T; Takashima A; Morita T; Mori H; Tomiyama T
Acta Neuropathol Commun; 2017 Jul; 5(1):59. PubMed ID: 28760161
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
Devi L; Ohno M
Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
[TBL] [Abstract][Full Text] [Related]
18. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
19. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?
Howlett DR; Richardson JC
Histol Histopathol; 2009 Jan; 24(1):83-100. PubMed ID: 19012248
[TBL] [Abstract][Full Text] [Related]
20. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
